SRPT
$17.10-3.88%
Sarepta Therapeutics Inc. Common Stock (DE)Stock · HealthcareRussell 2000 0.06%Nasdaq Composite 0.005%US Stock Market 0.002%Russell 3000 0.002%
Sarepta Therapeutics Inc. Common Stock (DE) total returns by year (including dividends)
As of market close, Oct 16, 2026
Sarepta Therapeutics Inc. Common Stock (DE) total returns by year (1998–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $21.52 | $17.10 | 0.0% | -20.5% | |
| 2025 | $121.59 | $21.52 | 0.0% | -82.3% | |
| 2024 | $96.43 | $121.59 | 0.0% | +26.1% | |
| 2023 | $129.58 | $96.43 | 0.0% | -25.6% | |
| 2022 | $90.05 | $129.58 | 0.0% | +43.9% | |
| 2021 | $170.49 | $90.05 | 0.0% | -47.2% | |
| 2020 | $129.04 | $170.49 | 0.0% | +32.1% | |
| 2019 | $109.13 | $129.04 | 0.0% | +18.2% | |
| 2018 | $55.64 | $109.13 | 0.0% | +96.1% | |
| 2017 | $27.43 | $55.64 | 0.0% | +102.8% | |
| 2016 | $38.58 | $27.43 | 0.0% | -28.9% | |
| 2015 | $14.47 | $38.58 | 0.0% | +166.6% | |
| 2014 | $20.37 | $14.47 | 0.0% | -29.0% | |
| 2013 | $25.80 | $20.37 | 0.0% | -21.0% | |
| 2012 | $4.50 | $25.80 | 0.0% | +473.3% | |
| 2011 | $12.72 | $4.50 | 0.0% | -64.6% | |
| 2010 | $8.76 | $12.72 | 0.0% | +45.2% | |
| 2009 | $3.96 | $8.76 | 0.0% | +121.2% | |
| 2008 | $8.46 | $3.96 | 0.0% | -53.2% | |
| 2007 | $19.08 | $8.46 | 0.0% | -55.7% | |
| 2006 | $20.70 | $19.08 | 0.0% | -7.8% | |
| 2005 | $14.10 | $20.70 | 0.0% | +46.8% | |
| 2004 | $24.42 | $14.10 | 0.0% | -42.3% | |
| 2003 | $30.00 | $24.42 | 0.0% | -18.6% | |
| 2002 | $65.46 | $30.00 | 0.0% | -54.2% | |
| 2001 | $28.50 | $65.46 | 0.0% | +129.7% | |
| 2000 | $32.63 | $28.50 | 0.0% | -12.6% | |
| 1999 | $24.00 | $32.63 | 0.0% | +35.9% | |
| 1998 | $40.88 | $24.00 | 0.0% | -41.3% |
- Annualized
- -3.1%
- 1998–2026
- Average year
- +26.9%
- 28 full years
- Best year
- +473.3%
- 2012
- Worst year
- -82.3%
- 2025
- Positive years
- 13/28
- 46% up
Annualized (CAGR)
-3.1%
1998–2026
Average year
+26.9%
28 full years
Best year
+473.3%
2012
Worst year
-82.3%
2025
Positive years
13/28
46% up
Total return by period#
Annual
-400%-200%0%200%400%
1998-41%'98
1999+36%
2000-13%'00
2001+130%
2002-54%'02
2003-19%
2004-42%'04
2005+47%
2006-7.8%'06
2007-56%
2008-53%'08
2009+121%
2010+45%'10
2011-65%
2012+473%'12
2013-21%
2014-29%'14
2015+167%
2016-29%'16
2017+103%
2018+96%'18
2019+18%
2020+32%'20
2021-47%
2022+44%'22
2023-26%
2024+26%'24
2025-82%
2026-21%'26
Methodology#
Total returns, dividends reinvested, measured on SRPT. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Sarepta Therapeutics Inc. Common Stock (DE)'s average annual return?
- Since 1998, Sarepta Therapeutics Inc. Common Stock (DE) (SRPT) has returned about -3.1% a year (the compound annual growth rate) and an average calendar-year return of 26.9%.
- What were Sarepta Therapeutics Inc. Common Stock (DE)'s best and worst years?
- Over 1998–2026, the best year was 2012 (+473.3%) and the worst was 2025 (-82.3%).
- How often is Sarepta Therapeutics Inc. Common Stock (DE) up in a year?
- 13 of the 28 full years since 1998 were positive — about 46% of the time.
More on Sarepta Therapeutics Inc. Common Stock (DE)
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100